1. Home
  2. KALA vs ICON Comparison

KALA vs ICON Comparison

Compare KALA & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • ICON
  • Stock Information
  • Founded
  • KALA 2009
  • ICON 2023
  • Country
  • KALA United States
  • ICON Greece
  • Employees
  • KALA N/A
  • ICON N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • ICON
  • Sector
  • KALA Health Care
  • ICON
  • Exchange
  • KALA Nasdaq
  • ICON Nasdaq
  • Market Cap
  • KALA 5.1M
  • ICON 4.7M
  • IPO Year
  • KALA 2017
  • ICON 2024
  • Fundamental
  • Price
  • KALA $0.89
  • ICON $0.84
  • Analyst Decision
  • KALA Buy
  • ICON Strong Buy
  • Analyst Count
  • KALA 3
  • ICON 1
  • Target Price
  • KALA $31.50
  • ICON $4.50
  • AVG Volume (30 Days)
  • KALA 1.6M
  • ICON 1.7M
  • Earning Date
  • KALA 11-19-2025
  • ICON 10-31-2025
  • Dividend Yield
  • KALA N/A
  • ICON 1129.27%
  • EPS Growth
  • KALA N/A
  • ICON N/A
  • EPS
  • KALA N/A
  • ICON N/A
  • Revenue
  • KALA N/A
  • ICON $6,137,000.00
  • Revenue This Year
  • KALA N/A
  • ICON $94.05
  • Revenue Next Year
  • KALA N/A
  • ICON $18.81
  • P/E Ratio
  • KALA N/A
  • ICON N/A
  • Revenue Growth
  • KALA N/A
  • ICON 25.60
  • 52 Week Low
  • KALA $0.61
  • ICON $0.70
  • 52 Week High
  • KALA $20.60
  • ICON $130.80
  • Technical
  • Relative Strength Index (RSI)
  • KALA 39.51
  • ICON 25.37
  • Support Level
  • KALA $0.61
  • ICON $0.70
  • Resistance Level
  • KALA $0.70
  • ICON $1.12
  • Average True Range (ATR)
  • KALA 0.09
  • ICON 0.14
  • MACD
  • KALA 0.25
  • ICON -0.01
  • Stochastic Oscillator
  • KALA 70.38
  • ICON 19.48

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About ICON Icon Energy Corp. Common stock

Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.

Share on Social Networks: